Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 AUD | -25.00% | -25.00% | -14.29% |
03-25 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
03-14 | Avecho to Push Forward with Phase III Trial of Anti-Insomnia Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-14.29% | 6.3M | |
+26.51% | 49.18B | |
+1.15% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.70% | 26.09B | |
-22.30% | 18.71B | |
+7.80% | 13.26B | |
+32.50% | 12.32B | |
+0.44% | 11.99B |
- Stock Market
- Equities
- AVE Stock
- News Avecho Biotechnology Limited
- Athenex Pharmaceutical Division Submits Avecho's Vitamin K Injection to US FDA